Literature DB >> 30888622

Activation of the Oxytocin Receptor Modulates the Expression of Synaptic Adhesion Molecules in a Cell-Specific Manner.

M Zatkova1,2, A Reichova1, Z Bacova1, Jan Bakos3,4.   

Abstract

Synaptic cell adhesion molecules, including neurexins and neuroligins, mediate the formation and maintenance of connections between neuronal cells. Although neurexins and neuroligins are known to interact with each other in a calcium-dependent manner and several neuropeptides have been shown to act through G protein-coupled receptors to increase intracellular calcium levels, no studies have examined the role of the neuropeptide oxytocin in association with adhesion molecules. Given that oxytocin receptors are located on presynaptic and postsynaptic membranes and that oxytocin exerts direct effects on neuronal excitability, it could be hypothesized that oxytocin affects the expression of cell surface adhesion molecules. In the present study, we show that incubation in the presence of oxytocin (1 μM, 48 h) exerted cell-specific effects on the levels of neurexin 2α, neurexin 2β, and neuroligin 3. Oxytocin significantly increased the mRNA expression levels of neurexin 2α, neurexin 2β, and neuroligin 3 in SH-SY5Y, U-87MG, and primary cerebellar cells. The effect of inhibiting oxytocin receptors on the expression of neurexin 2β was more dramatic in U-87MG cells than in SH-SY5Y cells. Oxytocin did not exert effects in primary corticohippocampal cells. Additionally, we measured the expression of selected GTPases to determine whether they could mediate the effects of oxytocin. Oxytocin induced a decrease in the mRNA level of Rac1 in U-87MG and primary cerebellar cells and exerted a stimulatory effect on the expression of RhoB at the gene and protein level in SH-SY5Y cells. These results suggest that the regulation of neurexins and neuroligins involves the activation of oxytocin receptors. These effects are likely mediated by the stimulation of RhoB GTPase, at least in certain types of cells.

Entities:  

Keywords:  Development; GTPases; Neurexins; Neuroligins; Oxytocin receptor

Mesh:

Substances:

Year:  2019        PMID: 30888622     DOI: 10.1007/s12031-019-01296-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  2 in total

Review 1.  Patterning molecules; multitasking in the nervous system.

Authors:  Rishard Salie; Vera Niederkofler; Silvia Arber
Journal:  Neuron       Date:  2005-01-20       Impact factor: 17.173

2.  Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.

Authors:  Lauren F Harkin; Susan J Lindsay; Yaobo Xu; Ayman Alzu'bi; Alexandra Ferrara; Emily A Gullon; Owen G James; Gavin J Clowry
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

  2 in total
  4 in total

Review 1.  Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin.

Authors:  Benjamin Jurek; Magdalena Meyer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-08       Impact factor: 5.555

2.  OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling.

Authors:  Liang Ding; Yong Fu; Nisha Zhu; Mengxiang Zhao; Zhuang Ding; Xiaoxin Zhang; Yuxian Song; Yue Jing; Qian Zhang; Sheng Chen; Xiaofeng Huang; Lorraine A O'Reilly; John Silke; Qingang Hu; Yanhong Ni
Journal:  Nat Commun       Date:  2022-08-31       Impact factor: 17.694

3.  Oxytocin accelerates tight junction formation and impairs cellular migration in 3D spheroids: evidence from Gapmer-induced exon skipping.

Authors:  Benjamin Jurek; Lucia Denk; Nicole Schäfer; Mohammad Saied Salehi; Sareh Pandamooz; Silke Haerteis
Journal:  Front Cell Neurosci       Date:  2022-10-03       Impact factor: 6.147

4.  Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons.

Authors:  Magdalena Meyer; Kerstin Kuffner; Julia Winter; Inga D Neumann; Christian H Wetzel; Benjamin Jurek
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.